Helical is the virtual AI lab for pharma, designed to turn bio foundation models into reproducible discovery systems so every scientist can test hypotheses in-silico at the speed of inference. The platform has two product surfaces — the Virtual Lab for biologists and translational scientists, and the Model Factory for ML engineers and data scientists - built on the same data, the same models, and the same results. By putting both sides in the same system, Helical closes the gap between computational predictions and biological decision-making, so teams that traditionally worked in silos can collaborate on the same evidence.
Helical
- Life Sciences
- London, United Kingdom
- £7.5m
- helical.bio
- Update Information
More venture news
- 15 Apr 2026

LightcastLightcast lands £20m in funding led by ARCH Venture Partners to advance single-cell analysis platform
EquityLife Sciences - 14 Apr 2026

HelicalHelical raises a £7.5m seed round led by redalpine to build virtual labs for pharma research
SeedLife Sciences - 31 Mar 2026

SemarionSemarion secures £2.9m in funding led by Parkwalk to accelerate cell-based drug discovery
EquityLife Sciences
